Clinical Trial Update: Clinical Trial Evaluating the Combination of Vandetanib and Dasatinib During and After Radiation Therapy (RT) in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) [Phase 1]

View source ↗

Summary

A completed Phase 1 clinical trial evaluating the combination of vandetanib and dasatinib during and after radiation therapy in children with newly diagnosed di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma

Drugs mentioned

• Caprelsa (vandetanib)
• Sprycel (dasatinib)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Diffuse Intrinsic Pontine Glioma | Phase 1 | Status: COMPLETED